Safety & practicalities

# What a sermorelin certificate of analysis can tell you

A certificate of analysis is evidence about the material and tests it identifies. It is not a universal certificate of safety, a clinical trial, or proof that a particular vial is appropriate for a patient.

DBBy [Daniel Brooks](https://sermorelinhub.com/about/daniel-brooks)Revised October 2026 · Research-based editorial

## First identify what was tested

A report may concern a bulk ingredient before compounding, a sample of a finished preparation, or another material entirely. Read the material name, batch identifier, test date, and organization responsible for the analysis. Ask the pharmacy how that document relates to the prescription it actually dispensed.

[FDA’s comparison of compounding provisions](https://www.fda.gov/drugs/human-drug-compounding/fdc-act-provisions-apply-human-drug-compounding) describes valid certificates of analysis as a condition for bulk drug substances under the relevant statutory pathways. That requirement concerns ingredient controls. It does not mean that a certificate for raw material answers every question about a finished prescription after preparation, packaging, storage, and shipping.

## A purity percentage has a specific scope

When a seller highlights a purity figure, ask what the assay measures and what result is being compared with which specification. A number can be accurate for the test performed while failing to address another property that matters. The impressive size of the percentage is not a substitute for knowing the question the laboratory asked.

For example, an ingredient-identity result does not by itself describe the amount of drug in a finished vial. A chemical purity claim should not be silently converted into a sterility claim. A report on one batch should not authenticate every shipment carrying the same ingredient name. The proper response to an unclear certificate is explanation from the pharmacy, not an attempt to perform an internet-based quality release yourself.

## Ask how the document is connected to your supply

The key practical question is traceability: does the report refer to material used in your preparation or the finished batch you received? Ask the pharmacy to explain mismatched names, dates, or lot identifiers. A website may show an example certificate for general information; an example cannot establish that your supply underwent the same testing.

A missing public download does not prove that a pharmacy lacks quality controls. Some technical records are not posted for consumers. Conversely, a downloadable document does not prove those controls are adequate. Ask for a plain-language account of what is checked, who reviews it, and what happens if a result fails. The purpose is an understandable answer, not collecting the largest possible packet of unfamiliar technical files. If a report uses an unfamiliar abbreviation, ask what it measures before interpreting a “pass” result. Passing one specification does not tell you which other specifications were examined.

## Testing sits inside a broader quality system

FDA’s [guidance on component controls](https://www.fda.gov/drugs/guidances-drugs/questions-and-answers-current-good-manufacturing-practice-requirements-control-components-and-drug) explains that reliance on supplier analyses in the manufacturing context includes additional controls, such as identity testing and establishing supplier reliability. This is an example of why a supplier document is not the entire quality process; it should not be read as an identical checklist for every type of compounder.

Ask how the dispensing organization handles preparation, packaging, dating, and complaints for your dosage form. A test result cannot repair a broken shipping chain or resolve unclear use instructions. Those remain separate questions. Similarly, a report dated months ago may be relevant to a properly identified batch, but the date alone does not tell you how the finished medication should be stored today.

## Quality evidence is different from benefit evidence

Even a well-characterized product needs a clinical reason for use. A certificate cannot show that sermorelin improves sleep, changes body composition, or provides an anti-aging benefit in your circumstances. Those questions require relevant human evidence and an individual clinical assessment.

FDA states that [compounded drugs are not FDA-approved](https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers). Laboratory documentation does not change that status. If a seller uses a certificate to imply approval, guaranteed safety, or guaranteed results, ask it to separate those claims. A credible explanation will tell you what the document supports, what it does not address, and who can answer the remaining pharmacy and clinical questions.

**A note on treatment**Compounded medications are not FDA-approved. A prescription requires an individual clinical evaluation. This site provides education, not medical advice or a guarantee of treatment.

## Keep exploring

- [How to check a sermorelin compounding pharmacy](https://sermorelinhub.com/research/sermorelin-compounding-pharmacy)
- [Spotting fake sermorelin pharmacy websites](https://sermorelinhub.com/research/sermorelin-fake-online-pharmacies)
- [Sermorelin beyond-use dates: which date matters?](https://sermorelinhub.com/research/sermorelin-beyond-use-date)

Comparing services? Start with our [best provider shortlist](https://sermorelinhub.com/best/sermorelin-providers), read our [provider reviews](https://sermorelinhub.com/providers) or [compare current offers](https://sermorelinhub.com/compare/sermorelin-providers).

## Sources & further reading

- [FDA: compounding provisions and bulk ingredient certificates of analysis](https://www.fda.gov/drugs/human-drug-compounding/fdc-act-provisions-apply-human-drug-compounding)
- [FDA: component controls and supplier certificates of analysis](https://www.fda.gov/drugs/guidances-drugs/questions-and-answers-current-good-manufacturing-practice-requirements-control-components-and-drug)
- [FDA: compounded drugs are not FDA-approved](https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers)

Canonical page: https://sermorelinhub.com/research/sermorelin-certificate-of-analysis
